deoxycytidine and Lymphoma, Non-Hodgkin

deoxycytidine has been researched along with Lymphoma, Non-Hodgkin in 54 studies

Research

Studies (54)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (3.70)	18.7374
1990's	3 (5.56)	18.2507
2000's	21 (38.89)	29.6817
2010's	23 (42.59)	24.3611
2020's	5 (9.26)	2.80

Authors

Authors	Studies
Imada, K; Kaneko, H; Mizutani, C; Nagata, O; Naka, R; Tada, K; Tashima, M	1
Bender, JD; Mizukawa, B; Perentesis, JP; Pommert, L; Rubinstein, JD	1
Altuntaş, F; Bakırtaş, M; Başçı, S; Batgi, H; Dal, MS; Darçın, T; İskender, D; Kızıl Çakar, M; Merdin, A; Şahin, D; Tetik, A; Uncu Ulu, B; Yiğenoğlu, TN; Yıldız, J	1
Li, J; Liu, Z; Mi, M; Wang, Y; Zhang, C; Zhang, L	1
Chen, X; Dong, T; Ji, J; Kuang, P; Li, J; Liu, J; Liu, T; Liu, Z; Shen, K; Zhang, C; Zhang, L	1
Chen, SB; Chen, ZG; Jie, GT; Lyu, X; Ma, DL; Wang, YL; Yan, SB	1
Smith, SD	1
Avigdor, A; Kedmi, M; Nagler, A; Ribakovsky, E; Zlotnick, M	1
Gutierrez, A	1
Elsamany, S; Elsirafy, M; Farooq, MU; Sakr, M; Shamaa, S	1
Kato, K	1
Dong, M; Gui, L; He, X; Liu, P; Qin, Y; Shi, Y; Yang, J; Yang, S; Zhang, C; Zhou, S	1
Chang, JB; Ding, XX; Jiang, JH; Ma, F; Wang, CP; Wang, N; Wang, QD; Zhang, Y	1
el Aziz, LM	1
Chen, BL; Liu, L; Qin, SH; Tan, QL; Zhao, Z	1
Alamoudi, S; Anglin, P; Baetz, T; Chen, BE; Cheung, M; Couban, S; Crump, M; Djurfeldt, MS; Hay, AE; Ismail, WS; Kouroukis, CT; Kuruvilla, J; Luminari, S; MacDonald, DA; Meyer, RM; Olney, HJ; Seftel, M; Shepherd, L; Turner, AR	1
Bae, SH; Baek, JH; Choi, Y; Jo, JC; Joo, YD; Kim, DY; Kim, H; Lee, JH; Lee, JL; Lee, KH; Lee, WS; Ryoo, HM	1
Andorsky, D; Beck, JT; Belada, D; Dakhil, S; Daly, R; Dean, JP; Failloux, N; Georgiev, P; Hübel, K; Inhorn, LF; Pavlyuk, M; Pettengell, R; Quick, D	1
Keating, GM	1
Fan, Y; Huang, ZY; Luo, LH; Yu, HF	1
Cheng, AL; Kuo, SH; Lin, ZZ; Yang, SH	1
Eom, HS; Kim, JS; Kim, WS; Lee, DH; Lee, YY; Oh, SJ; Park, BB; Suh, C	1
Chen, CW; Cheng, AL; Chiang, CT; Feng, WC; Gao, M; Hsu, CH; Kuo, SH; Lu, YS; Yeh, LC; Yeh, PY	1
Aurer, I; Baila, L; Eghbali, H; Fortpied, C; Khaled, HM; Raemaekers, J; van der Maazen, RW	1
Butera, JN; Mega, AE; Nadeem, A; Reagan, JL; Rosmarin, A; Schiffman, FJ; Sikov, WM; Winer, E	1
Bollard, CM; Buglio, D; Derenzini, E; Illés, A; Ji, Y; Jóna, A; Khaskhely, N; Medeiros, LJ; Shafer, JA; Younes, A	1
Filatova, LV; Gershanovich, ML; Latipova, DKh; Semiglazova, TIu; Stukov, AN; Tarasenkova, AA; Vershinina, SF	1
Cook, L; Hughes, G; Kanfer, EJ; Karadimitris, A; Macdonald, DH; Marks, AJ; Matthey, F; Naresh, KN; Sivam, V; Szydlo, RM; Yarranton, H	1
Filatova, LV; Gershanovich, ML; Latinova, DKh; Semiglazova, TIu; Stukov, AN; Tarasenkova, AA; Vershinina, SF; Zargarova, NI	1
Bai, B; Bu, Q; Cai, QC; Cai, QQ; Gao, Y; Guo, Y; Huang, HQ; Lin, ZX; Wang, XX; Xia, Y	1
Chau, I; Cunningham, D; Watkins, D	1
Dumontet, C	1
Li, A; Luo, R; Ma, S; Sheng, X	1
Adams, G; Baetz, T; Belch, A; Couban, S; Crump, M; Ding, K; Howson-Jan, K; Iglesias, J; Imrie, K; Marcellus, D; Meyer, R; Myers, R; Paul, N; Shepherd, L	1
Airoldi, M; Cagliero, E; Cattel, L; Goffredo, F; Passera, R; Stella, B	1
Herrmann, R; Pless, M; Rochlitz, Ch; Stern, M; Wenger, C	1
Larson, BJ; Lynch, JW; Mendenhall, NP; Pusateri, A; Waples, JM	1
Dührsen, U; Kasper, C; Müller-Beissenhirtz, H; Nückel, H	1
Jin, F; Joshi, I; Obasaju, C; Smith, MR	1
Brugiatelli, M; Cervetti, G; Di Renzo, N; Federico, M; Giglio, G; Liberati, AM; Luminari, S; Montanini, A; Spedini, P; Vigliotti, ML	1
Gardner, J; Gonen, M; Heaney, M; O'Connor, OA; Sirotnak, F; Smith, EA; Teruya-Feldstein, J; Toner, LE; Vrhovac, R	1
Avritscher, EB; Bekele, BN; Cooksley, CD; Elting, LS; Jones, JA; Michelet, M	1
Smith, S	1
Cupelli, L; de Fabritis, P; Dentamaro, T; Giovannini, M; Niscola, P; Palombi, M; Perrotti, AP; Piccioni, D; Scaramucci, L; Tendas, A	1
Bernell, P; Ohm, L	1
Cheson, BD	1
Bonadonna, G; Buksmaui, S; Fosså, A; Hiddemann, W; Niederle, N; Nowrousian, MR; Santoro, A; Seeber, S; Truemper, L	1
Flamm, M; Garrett, TJ; Heitjan, D; Johnson, SA; Keohan, ML; Lee, RT; Oster, MW; Ruiz, J; Rule, SA; Savage, DG; Tighe, M	1
Genvresse, I; Harder, H; Lange, C; Possinger, K; Schanz, J; Schweigert, M; Späth-Schwalbe, E	1
Bouafia, F; Bourgeois, E; Coiffier, B; Dumontet, C; Hequet, O; Leleu, X; Morschhauser, F; Salles, G; Solal-Celigny, P; Thieblemont, C	1
Brunson, CY; Green, MR; Kneuper-Hall, R; Lal, A; Rocha Lima, CM; Urbanic, JJ	1
Gandhi, V; Krett, N; Nabhan, C; Rosen, S	1
Bobo, B; Drewinko, B	1
Higa, E; Meyer, JS	1

Reviews

7 review(s) available for deoxycytidine and Lymphoma, Non-Hodgkin

Article	Year
[Malignant lymphoma and adult T-cell leukemia-lymphoma]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Deoxycytidine; Dexamethasone; Doxorubicin; Etoposide; Genetic Markers; Genetic Testing; Hodgkin Disease; Humans; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, Non-Hodgkin; Methylprednisolone; Positron-Emission Tomography; Prednisone; Vincristine	2014
Pixantrone: A Review in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma. Drugs, 2016, Volume: 76, Issue:16 Topics: Adult; Antineoplastic Agents; Deoxycytidine; Gemcitabine; Humans; Isoquinolines; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Rituximab	2016
Gemcitabine and its combinations in the treatment of malignant lymphoma. Clinical lymphoma, 2002, Volume: 3, Issue:2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Gemcitabine; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Random Allocation; Recurrence; Rituximab; Transplantation, Autologous; Treatment Outcome	2002
[The role of gemcitabine in hematology]. Bulletin du cancer, 2002, Volume: 89 Spec No Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Deoxycytidine; DNA Damage; DNA, Neoplasm; Drug Design; Gemcitabine; Hematologic Neoplasms; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Multiple Myeloma; Neoplasm Proteins; Nucleotides; Ribonucleotide Reductases; Salvage Therapy; Treatment Outcome	2002
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2006, Volume: 14, Issue:6 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Colorectal Neoplasms; Cyclophosphamide; Deoxycytidine; Doxorubicin; Female; Fluorouracil; Gastrointestinal Diseases; Gemcitabine; Humans; Incidence; Lung Neoplasms; Lymphoma, Non-Hodgkin; Mucositis; Neoplasms; Prednisone; Radiotherapy; Severity of Illness Index; Stomatitis; Taxoids; Vinblastine; Vincristine; Vinorelbine	2006
Beyond pancreatic cancer: irinotecan and gemcitabine in solid tumors and hematologic malignancies. Seminars in oncology, 2001, Volume: 28, Issue:3 Suppl 10 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Colorectal Neoplasms; Deoxycytidine; Gemcitabine; Hematologic Neoplasms; Humans; Irinotecan; Lung Neoplasms; Lymphoma, Non-Hodgkin; Pancreatic Neoplasms	2001
Gemcitabine in hematologic malignancies. Current opinion in oncology, 2001, Volume: 13, Issue:6 Topics: Antimetabolites, Antineoplastic; Clinical Trials as Topic; Deoxycytidine; DNA; Gemcitabine; Hodgkin Disease; Humans; Leukemia; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Tumor Cells, Cultured	2001

Trials

19 trial(s) available for deoxycytidine and Lymphoma, Non-Hodgkin

Article	Year
A new conditioning regimen with chidamide, cladribine, gemcitabine and busulfan significantly improve the outcome of high-risk or relapsed/refractory non-Hodgkin's lymphomas. International journal of cancer, 2021, 12-15, Volume: 149, Issue:12 Topics: Adolescent; Adult; Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Busulfan; Cladribine; Deoxycytidine; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gemcitabine; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Progression-Free Survival; Transplantation Conditioning; Transplantation, Autologous; Young Adult	2021
[Efficacy Analysis of GEMOX Regimen for Treatment of Refractory Non-Hodgkin's Lymphoma]. Zhongguo shi yan xue ye xue za zhi, 2017, Volume: 25, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Organoplatinum Compounds; Oxaliplatin; Treatment Outcome; Vinblastine; Vinorelbine	2017
Phase II study of low-dose fixed-rate infusion of gemcitabine combined with cisplatin and dexamethasone in resistant non-Hodgkin lymphoma and correlation with Bcl-2 and MDR expression. Medical oncology (Northwood, London, England), 2014, Volume: 31, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cisplatin; Cohort Studies; Deoxycytidine; Dexamethasone; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gemcitabine; Humans; Immunoenzyme Techniques; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prognosis; Proto-Oncogene Proteins c-bcl-2; Remission Induction; Salvage Therapy; Survival Rate; Young Adult	2014
Survivin as prognostic and predictive factor in patients treated with gemcitabine, dexamethasone, and cisplatin for relapsed or refractory aggressive NHL. Medical oncology (Northwood, London, England), 2014, Volume: 31, Issue:11 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Deoxycytidine; Dexamethasone; Female; Follow-Up Studies; Gemcitabine; Humans; Inhibitor of Apoptosis Proteins; Lymphoma, Non-Hodgkin; Male; Middle Aged; Predictive Value of Tests; Prognosis; Recurrence; Survival Rate; Survivin; Treatment Outcome; Young Adult	2014
Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12. Blood, 2015, Aug-06, Volume: 126, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Deoxycytidine; Dexamethasone; Etoposide; Female; Follow-Up Studies; Gemcitabine; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Prognosis; Recurrence; Salvage Therapy; Survival Analysis; Time Factors; Transplantation, Autologous	2015
Biweekly dose-dense gemcitabine-oxaliplatin and dexamethasone for relapsed/refractory aggressive non-Hodgkin lymphoma: A multicenter, single-arm, phase II trial. Asia-Pacific journal of clinical oncology, 2016, Volume: 12, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Female; Gemcitabine; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Remission Induction; Salvage Therapy; Treatment Outcome	2016
Pixantrone-rituximab versus gemcitabine-rituximab in relapsed/refractory aggressive non-Hodgkin lymphoma. Future oncology (London, England), 2016, Volume: 12, Issue:15 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Isoquinolines; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Research Design; Rituximab	2016
Gem-(R)CHOP versus (R)CHOP: a randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's lymphoma--EORTC lymphoma group protocol 20021 (EudraCT number 2004-004635-54). European journal of haematology, 2011, Volume: 86, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Doxorubicin; Europe; Female; Gemcitabine; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisolone; Prognosis; Time Factors; Treatment Outcome; Vincristine	2011
Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHL. Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:4 Topics: Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, Non-Hodgkin; Maximum Tolerated Dose; Middle Aged; Prednisone; Rituximab; Survival Rate; Treatment Outcome; Vincristine	2011
Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG). Cancer, 2004, Oct-15, Volume: 101, Issue:8 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dexamethasone; Female; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Stem Cell Transplantation; Treatment Outcome	2004
Gemcitabine plus vinorelbine chemotherapy regimens: a pharmacokinetic study of alternate administration sequences. Pharmacy world & science : PWS, 2004, Volume: 26, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Drug Administration Schedule; Drug Interactions; Forecasting; Gemcitabine; Half-Life; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Italy; Kinetics; Lymphoma, Non-Hodgkin; Vinblastine; Vinorelbine	2004
Rituximab plus gemcitabine: a therapeutic option for elderly or frail patients with aggressive non Hodgkin's lymphoma? Leukemia & lymphoma, 2005, Volume: 46, Issue:1 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Deoxycytidine; Drug Therapy, Combination; Female; Frail Elderly; Gemcitabine; Humans; Immunotherapy; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Rituximab; Survival Rate	2005
A phase II study of gemcitabine in patients with relapsed or refractory low-grade non-Hodgkin lymphoma. American journal of clinical oncology, 2005, Volume: 28, Issue:2 Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged	2005
Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma, results of a phase II single center study. Annals of hematology, 2005, Volume: 84, Issue:12 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Gemcitabine; Graft vs Host Disease; Humans; Infections; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Recurrence; Remission Induction; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine	2005
Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi. Leukemia & lymphoma, 2006, Volume: 47, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Recurrence; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vinorelbine	2006
Promising activity of gemcitabine in refractory high-grade non-Hodgkin's lymphoma. British journal of haematology, 1998, Volume: 101, Issue:1 Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, Non-Hodgkin; Treatment Outcome	1998
Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:12 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Treatment Outcome	1999
Gemcitabine for relapsed or resistant lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:5 Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Hodgkin Disease; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Treatment Outcome	2000
Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma. British journal of haematology, 2001, Volume: 113, Issue:3 Topics: Adult; Aged; Antimetabolites; Capillary Leak Syndrome; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Fever; Gemcitabine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukopenia; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Myocardial Infarction; Pulmonary Veno-Occlusive Disease; Recurrence; Renal Insufficiency; Survival Rate; Thrombocytopenia; Time Factors	2001

Other Studies

28 other study(ies) available for deoxycytidine and Lymphoma, Non-Hodgkin

Article	Year
Effectiveness and safety of R-GCD (rituximab, gemcitabine, carboplatin, and dexamethasone) for transplant-ineligible relapse/refractory diffuse large B-cell lymphoma and grade 3a follicular lymphoma: a retrospective analysis comparing with R-GDP (rituxima Leukemia & lymphoma, 2022, Volume: 63, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Dexamethasone; Gemcitabine; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Retrospective Studies; Rituximab; Salvage Therapy	2022
Use of gemcitabine, oxaliplatin, and anti-CD20 therapy in children and adolescents with non-Hodgkin lymphoma unfit for intensive therapy. Pediatric blood & cancer, 2023, Volume: 70, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Deoxycytidine; Gemcitabine; Humans; Lymphoma, Non-Hodgkin; Oxaliplatin; Retrospective Studies; Rituximab; Treatment Outcome	2023
The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dexamethasone; Female; Gemcitabine; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Young Adult	2020
Gemcitabine, cisplatin, and dexamethasone and ifosfamide, carboplatin, and etoposide regimens have similar efficacy as salvage treatment for relapsed/refractory aggressive lymphoma: A retrospectively comparative study. Medicine, 2020, Dec-04, Volume: 99, Issue:49 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Dexamethasone; Etoposide; Female; Gemcitabine; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Salvage Therapy; Young Adult	2020
Gemcitabine: End of a Chemotherapy's Era? Acta haematologica, 2019, Volume: 141, Issue:2 Topics: Deoxycytidine; Gemcitabine; Humans; Lymphoma, Non-Hodgkin; Salvage Therapy	2019
Efficacy of Gemcitabine as Salvage Therapy for Relapsed and Refractory Aggressive Non-Hodgkin Lymphoma. Acta haematologica, 2019, Volume: 141, Issue:2 Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Deoxycytidine; Disease-Free Survival; Drug Therapy, Combination; Female; Gemcitabine; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Positron Emission Tomography Computed Tomography; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Young Adult	2019
Current Real-Life Results and Future Options of Gemcitabine-Based Salvage Therapy for Relapsed or Refractory Non-Hodgkin Lymphoma. Acta haematologica, 2019, Volume: 141, Issue:3 Topics: Deoxycytidine; Gemcitabine; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Salvage Therapy	2019
[Efficacy and safety evaluation of gemcitabine combined with oxaliplatin in lymphoma patients after failure of multiple chemotherapy regimens]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2014, Volume: 36, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Remission Induction; Salvage Therapy; Thrombocytopenia; Young Adult	2014
FNC, a novel nucleoside analogue, blocks invasion of aggressive non-Hodgkin lymphoma cell lines via inhibition of the Wnt/β-catenin signaling pathway. Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:16 Topics: Antineoplastic Agents; Azides; beta Catenin; Cadherins; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Deoxycytidine; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lymphoma, Non-Hodgkin; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; RNA, Messenger; Vascular Endothelial Growth Factor A; Wnt Proteins; Wnt Signaling Pathway	2014
[Safety and efficacy evaluation of gemcitabine combined with oxaliplatin for the treatment of patients with lymphoma]. Zhongguo shi yan xue ye xue za zhi, 2015, Volume: 23, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Gemcitabine; Humans; Lymphoma, Non-Hodgkin; Organoplatinum Compounds; Oxaliplatin	2015
[Efficacy of GDP regimen (gemcitabine, dexamethasone, and cisplatin) on relapsed or refractory aggressive non-Hodgkin's Lymphoma: a report of 24 cases]. Ai zheng = Aizheng = Chinese journal of cancer, 2008, Volume: 27, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dexamethasone; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Thrombocytopenia; Young Adult	2008
Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma. American journal of hematology, 2009, Volume: 84, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Glucocorticoids; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy	2009
Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin's lymphoma: a consortium for improving survival of lymphoma (CISL) trial. Investigational new drugs, 2011, Volume: 29, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Deoxycytidine; Dexamethasone; Disease-Free Survival; Female; Gemcitabine; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Salvage Therapy; Treatment Outcome; Young Adult	2011
Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma. Cancer letters, 2010, Dec-08, Volume: 298, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Caspases; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Everolimus; Gemcitabine; Humans; Immunosuppressive Agents; Jurkat Cells; Lymphoma, Non-Hodgkin; Myeloid Cell Leukemia Sequence 1 Protein; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases	2010
The histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in Hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitors. Experimental hematology, 2011, Volume: 39, Issue:10 Topics: Acetylation; Apoptosis; Apoptosis Regulatory Proteins; Benzamides; Biphenyl Compounds; Boronic Acids; Bortezomib; Cyclin-Dependent Kinase Inhibitor p21; Deoxycytidine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Gemcitabine; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histones; Hodgkin Disease; Humans; Indoles; Lymphoma, Non-Hodgkin; Neoplasm Proteins; Nitrophenols; Piperazines; Protein Processing, Post-Translational; Pyrazines; Pyridines; Pyrroles; Sulfonamides; Tumor Cells, Cultured; X-Linked Inhibitor of Apoptosis Protein	2011
[Investigation of gemcitabine plus lomustine treatment in mice with transplantable lymphosarcoma LIO-1]. Voprosy onkologii, 2011, Volume: 57, Issue:2 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gemcitabine; Lomustine; Lymphoma, Non-Hodgkin; Maximum Tolerated Dose; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Random Allocation	2011
Gemcitabine and vinorelbine chemotherapy for refractory or relapsing aggressive non-Hodgkin lymphoma. Hematological oncology, 2012, Volume: 30, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Salvage Therapy; Survival Rate; Vinblastine; Vinorelbine; Young Adult	2012
[Combined effect of gemcitabine and lomustine in mice with intracranial transplanted lymphosarcoma LIO-1]. Voprosy onkologii, 2012, Volume: 58, Issue:3 Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Synergism; Gemcitabine; Injections, Intraperitoneal; Lomustine; Lymphoma, Non-Hodgkin; Male; Maximum Tolerated Dose; Mice; Survival Analysis	2012
Promising long-term outcome of gemcitabine, vinorelbine, liposomal doxorubicin (GVD) in 14-day schedule as salvage regimen for patients with previously heavily treated Hodgkin's lymphoma and aggressive non-Hodgkin's lymphoma. Medical oncology (Northwood, London, England), 2013, Volume: 30, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Salvage Therapy; Time; Treatment Outcome; Vinblastine; Vinorelbine	2013
[Gemcitabine in the treatment of relapsed or refractory non-Hodgkin's lymphoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2002, Volume: 24, Issue:6 Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Salvage Therapy; Secondary Prevention	2002
Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scid mice. BMC cancer, 2005, Aug-18, Volume: 5 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Coloring Agents; Combined Modality Therapy; Deoxycytidine; Gemcitabine; In Vitro Techniques; Inhibitory Concentration 50; Lymphoma, Non-Hodgkin; Mice; Mice, SCID; Neoplasm Transplantation; Poly(ADP-ribose) Polymerases; Rituximab; Tetrazolium Salts; Thiazoles; Translocation, Genetic	2005
The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Feb-01, Volume: 12, Issue:3 Pt 1 Topics: Aminopterin; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cytarabine; Deoxycytidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Gemcitabine; Humans; In Vitro Techniques; Lymphoma, Non-Hodgkin; Methotrexate; Mice; Mice, SCID; Time Factors; Xenograft Model Antitumor Assays	2006
Something old, something new.... Leukemia & lymphoma, 2006, Volume: 47, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Lymphoma, Non-Hodgkin; Prednisone; Procarbazine; Recurrence; Stem Cell Transplantation; Time Factors; Treatment Outcome; Vinblastine; Vinorelbine	2006
Vinorelbine and gemcitabine as salvage treatment in advanced and very poor prognosis non-Hodgkin's lymphoma patients. Annals of hematology, 2008, Volume: 87, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Deoxycytidine; Gemcitabine; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prognosis; Salvage Therapy; Treatment Failure; Treatment Outcome; Vinblastine; Vinorelbine	2008
New prospects in the treatment of indolent lymphomas with purine analogues. The cancer journal from Scientific American, 1998, Volume: 4 Suppl 2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Pentostatin; Vidarabine	1998
Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative study. Anti-cancer drugs, 2001, Volume: 12, Issue:4 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Amifostine; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; Deoxycytidine; Doxorubicin; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Gemcitabine; Humans; Hypertension; Hypocalcemia; Hypotension; Infusions, Intravenous; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Paclitaxel; Pancreatic Neoplasms; Platinum; Prednisone; Premedication; Retrospective Studies; Vincristine	2001
Inhibition of [3H]TdR and [3H]CdR incorporation in an established human lymphoma cell line by trypsin treatment. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1978, Volume: 158, Issue:4 Topics: Animals; Cell Line; Cell Separation; Deoxycytidine; DNA, Neoplasm; HeLa Cells; Humans; Lymphoma, Non-Hodgkin; Melanoma; Neoplasms, Experimental; Sarcoma, Experimental; Thymidine; Trypsin	1978
S-phase fractions of cells in lymph nodes and malignant lymphomas. Archives of pathology & laboratory medicine, 1979, Volume: 103, Issue:2 Topics: Cell Cycle; Deoxycytidine; Deoxyuridine; Humans; Interphase; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Radionuclide Imaging	1979